[1]
2024. Biohazard Levels In Laboratory Practice And Pharmaceutical Supply Chains: Implications For Healthcare Security And Medical Laboratory Operations. The Review of Diabetic Studies . (Jun. 2024), 820–830. DOI:https://doi.org/10.70082/ax0a7836.